Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in α-conotoxin MII sites

Molecular Pharmacology

Volumn 61, Issue 1, 2002, Pages 230-238

  Kulak, Jennifer M ^a   Michael McIntosh, J ^b   Quik, Maryka ^a  

^a PARKINSON S INSTITUTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; CHOLINERGIC RECEPTOR; CONOTOXIN; CYTISINE; DOPAMINE TRANSPORTER; EPIBATIDINE; IODINE 125; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BINDING AFFINITY; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; FRONTAL CORTEX; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRIATONIGRAL DEGENERATION; THALAMUS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; CAUDATE NUCLEUS; CONOTOXINS; CORPUS STRIATUM; DOPAMINE AGENTS; IODINE RADIOISOTOPES; MOTOR ACTIVITY; NICOTINIC AGONISTS; PUTAMEN; PYRIDINES; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; SAIMIRI;

EID: 0036144163     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.1.230     Document Type: Article

References (40)

1. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders
2. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors
3. 50) of an enzymatic reaction
4. Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: Localization of α3 subunit mRNA, α-bungarotoxin and nicotine binding sites
5. Nicotinic receptor function: New perspectives from knockout mice
6. Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication
7. 125I-IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors
8. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment
9. Human neuronal nicotinic receptors
10. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: A function mediated by a different nAChR than dopamine release from striatum
11. Localization of nAChR subunit mRNAs in the brain of Macaca mulatta
12. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain
13. Nicotinic receptors in the brain: Correlating physiology with function
14. 3H]dopamine release from rat striatal synaptosomes and slices
15. The effects of nicotine on Parkinson's disease
16. α-conotoxin MII blocks nicotine-stimulated dopamine release from rat striatal synaptosomes
17. Differential alterations in non-α7 and α7 nicotinic receptors in monkey striatum after MPTP treatment
18. Human α6 AChR subtypes: Subunit composition, assembly, and pharmacological responses
19. Parkinson's disease. First of two parts
20. Investigating levodopa-induced dyskinesias in the parkinsonian primate
21. Presynaptic ionotropic receptors and the control of transmitter release
22. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain
23. Nicotinic binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine, and alpha-bungarotoxin
24. Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease
25. Conus peptides: Novel probes for nicotinic acetylcholine receptor structure and function
26. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes
27. Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
28. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases
29. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety
30. Nicotinic receptors and Parkinson's disease
31. Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization
32. Differential alterations in nicotinic receptor α6 and β3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration
33. 125I-α-conotoxin MII binding sites to nigrostriatal damage in monkey
34. Functional contributions of α5 subunit to neuronal acetylcholine receptor channels
35. Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: Comparison with levodopa treatment
36. Functional α6-containing nicotinic receptors are present in chick retina
37. 125I-epibatidine
38. Pharmacological and null mutation approaches reveal nicotinic receptor diversity
39. 125I-α-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain